Congratulations to Dr. Dylan O’Sullivan who has been awarded his first grant as Principal Investigator by the Charbonneau Cancer Institute. Dylan was awarded a one-year Team Accelerator Grant for $75,000 for the project entitled: “Improving screening among adult cancer survivors: identifying survivors at elevated risk of developing new primary cancers.” The co-applicants on this project are Drs H Yang, RJ Hilsden, T Tremblay, C Cuthbert, S Lupichuk, P Tang, S Karim, WY Cheung, DR Brenner, T Jarada, M Warkentin and S Rahn. The goal of this project is to estimate the risk of developing or dying from second primary cancers that could be screened for (i.e., breast, colorectal, cervical and lung cancers) among cancer survivors using historical cancer data from Alberta. In addition, the project aims to identify patient and disease characteristics, medical history and treatment-related factors that are associated with developing or dying from these second primary cancers. The results of this study will inform clinical care on the appropriate follow-up screening and care after a first primary cancer. Even though cancer survivors are at increased risk for new cancers compared to the general population, no screening guidelines for cancer survivors exist and adherence to screening among cancer survivors is suboptimal. Hence, this project addresses an important gap in cancer clinical care.